Efficient tumour formation by single human melanoma cellsElsa Quintana, Sean J. Morrison|Nature|2008Cited by 1.8k
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Mallika Singh, Elena S. Koltun et al.|Nature|2024Cited by 319
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUğur Eskiocak, Sean J. Morrison, Vijayashree Ramesh et al.|Nature Communications|2016Cited by 69
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N. Wasko, Kenneth P. Olive, Jingjing Jiang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 11
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Sumit Kar et al.|Molecular Cancer Therapeutics|2025Cited by 1